To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers

NCT02179970 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma Metastatic
Ovarian Serous Adenocarcinoma
Colorectal Cancer Metastatic

Interventions

DRUG: Plerixafor

Sponsor

CCTU- Cancer Theme

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]